ADVANCED TUMORS
Clinical trials for ADVANCED TUMORS explained in plain language.
Never miss a new study
Get alerted when new ADVANCED TUMORS trials appear
Sign up with your email to follow new studies for ADVANCED TUMORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy targets Hard-to-Treat tumors
Disease control CompletedThis early-stage study tested a new drug called RiMO-301, injected directly into tumors, combined with radiation therapy. It involved 32 adults with advanced cancers that could not be cured by standard treatments. The main goal was to find the safest dose and see if the combinati…
Matched conditions: ADVANCED TUMORS
Phase: PHASE1 • Sponsor: Coordination Pharmaceuticals, Inc. • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
Immunotherapy cocktail shows promise against tough cancers
Disease control CompletedThis study tested a new immunotherapy drug called ezabenlimab (BI 754091) combined with other cancer medicines in 211 adults with advanced solid tumors that had spread. The goal was to see if the combinations could shrink or eliminate tumors. Participants received treatment until…
Matched conditions: ADVANCED TUMORS
Phase: PHASE2 • Sponsor: Boehringer Ingelheim • Aim: Disease control
Last updated May 14, 2026 12:04 UTC